A randomized controlled trial of the cost-utility of second-generation antipsychotics in people with psychosis and eligible for clozapine

Linda Davies, Thomas R E Barnes, Peter B. Jones, Shôn Lewis, Fiona Gaughran, Karen Hayhurst, Alison Markwick, Helen Lloyd

Research output: Contribution to journal › Article › peer-review

1 Article

1 results

2006
Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment
Lewis, S. W., Davies, L., Jones, P. B., Barnes, T. R. E., Murray, R. M., Kerwin, R., Taylor, D., Hayhurst, K., Markwick, A., Lloyd, H. & Dunn, G., May 2006, In: Health Technology Assessment. 10, 17, p. 1-165 165 p.
Research output: Contribution to journal › Article › peer-review

Open Access